New drug combo aims to heal wounds faster and reduce scars

NCT ID NCT05844527

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a new drug called MRG-001 in 10 people who had tummy tuck surgery. The drug is injected under the skin to help stem cells move to the wound and speed healing. Researchers compared the drug to a saltwater placebo to see if it makes scars stronger and less noticeable.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
MRG-001 (a combination of plerixafor and tacrolimus)
What this could lead to
If it works, this could point toward a treatment that speeds wound healing and reduces scarring after surgery.
What could go wrong
This is a very small early-phase trial with only 10 participants, so results may not apply to everyone. The drug combination is new and its safety and effectiveness are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ABDOMINAL WOUND are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Northwestern University Feinberg School of Medicine

    Chicago, Illinois, 60611, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.